Wegovy vs Zepbound Cost 2026: Which Is Actually Cheaper?
Both start near $299 a month at the manufacturer, and that headline hides almost everything that matters — dose ladders, refill windows, and which one your insurance will actually touch.
The short answer#
The differences that matter#
| Wegovy | Zepbound | |
|---|---|---|
| Cheapest entry | Wegovy pill from $149/mo | Zepbound from $299/mo (2.5 mg) |
| Top standard dose price | $349/mo pen (all standard doses); $399 at 7.2 mg | $449/mo (7.5–15 mg) |
| Dose-price behaviour | Pen is flat across standard doses — your price does not climb | Climbs with dose, so year one costs more than month one |
| The catch | Oral form has food-and-water timing rules | Maintenance pricing requires refilling within 45 days |
| Medicare Bridge ($50 copay) | Pen and pill both included | KwikPen only — vials excluded |
| Trial average weight loss | ~15% over 68 weeks (STEP 1) | ~15–21% over 72 weeks (SURMOUNT-1) |
Cheapest channels for each, right now#
Sources#
Run your own numbers with the GLP-1 cost calculator, check whether you're overpaying with the price checker, or see every comparison we publish.
Common questions#
Wegovy vs Zepbound Cost 2026?#
On trial averages, tirzepatide (Zepbound) produced greater weight loss than semaglutide in the head-to-head SURMOUNT-5 trial. On price, Wegovy has something Zepbound does not: a $149 oral entry point. If you want the cheapest legitimate start, that is Wegovy's pill. If you want the strongest average trial result and can absorb $299–$449, that is Zepbound.
Comparisons of approved uses, mechanisms, and published trial averages — not medical advice, and averages are not individuals. Which medication suits you is a decision for you and a licensed clinician. Prices carry the verification dates shown. No link on this page earns us a commission; comparisons are computed from data, never compensation — disclosure.